Metraipolis › archive › dc_ede911a2dc4b

Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study — Europe PMC PMID:42256393

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42256393
DOI
10.3389/fphar.2026.1811121
License (as archived)
solo-consultazione
Archived
2026-11-01T09:55:38.423Z
SHA-256 of the archived text
d1a6559c08298e8a59e72b1fecaf7918e8f91ef8264a47f05b24fc0621714e0b
Stable URL of this page
https://metraipolis.com/documento/dc_ede911a2dc4b

How to cite

Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study — Europe PMC PMID:42256393 — Europe PMC (en), https://europepmc.org/article/MED/42256393 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ede911a2dc4b (Metraipolis archive dc_ede911a2dc4b, sha256 d1a6559c08298e8a59e72b1fecaf7918e8f91ef8264a47f05b24fc0621714e0b)
BibTeX
@misc{dcede911a2dc4b,
  title = {Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study — Europe PMC PMID:42256393},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42256393},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ede911a2dc4b; sha256 d1a6559c08298e8a59e72b1fecaf7918e8f91ef8264a47f05b24fc0621714e0b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42256393. Agents can read the archived copy with the MCP tool read_document.